Clinilabs congratulates Larimar Therapeutics Inc. on their Topline Phase 1 Clinical Trial Data in patients with Friedreich’s Ataxia! We are proud to have been part of this clinical trial and to have worked with this partner who is dedicated to bringing life changing treatments to patients with this rare disease. To learn more about this [...]
2020 will go down as a miserable year, but beyond the heartache, some developments may represent bright spots that light the way to the future. One of these is the growth of Decentralized Clinical Trials (DCTs). DCTs are virtual trials that integrate remote assessments with modern digital health technologies, including remote rating apps, wearable monitoring [...]
T3D Therapeutics, Inc. (“T3D Therapeutics” or the “Company”), a biopharmaceutical company specializing in the development of ‘First-in-Class’ and ‘Best-in-Class’ disease-modifying, breakthrough medicine for the treatment of Alzheimer’s disease and other neurodegenerative diseases, announced it has engaged Clinilabs Drug Development Corporation (“Clinilabs”) as the contract research organization (“CRO”) for its upcoming phase 2 trial of T3D-959 named the PIONEER [...]
We know how unsettling these times are for everyone - especially for those of us in the clinical trials space who need guidance on how to manage the demands of ongoing and future CNS clinical trials. Despite these challenges, we know now more than ever, the importance of the scientific community and the medical [...]
By now, you have likely heard about the Coronavirus (officially called “2019-Novel Coronavirus” or “COVID-19”) in the news. While the immediate health risk remains low to Americans, there are still ways that all of us can play a role in helping to prevent the spread of this and other viruses. With that said, Clinilabs, the [...]
Clinilabs Drug Development Corporation, the only global, full-service contract research organization (CRO) focused exclusively on central nervous system (CNS) drug development, was engaged by a large, clinical-stage biopharmaceutical company to manage a randomized, double-blind, placebo-controlled study of a therapy for patients with acute migraine headache. The pivotal trial, involving 100 sites, various demographics and [...]
Clinilabs Drug Development Corporation, a mid-sized, full-service CRO that provides a full range of clinical drug development services, has been utilizing Facebook advertising as an essential tool for generating study participant leads with good success. In fact, Facebook recruitment has been one of Clinilabs’ fastest responding and lowest cost recruitment tools. But even with the [...]
In the spirit of the holidays, your friends at Clinilabs Drug Development Corporation would like to celebrate by spreading some holiday cheer. We hope you have as much fun watching it as we did making it!
Clinilabs Drug Development Corporation, a CNS-focused contract research organization, and SureClinical, a global provider of innovative cloud solutions for the health sciences market, are sponsoring a global Lunch & Learn series demonstrating how sponsors can streamline and accelerate the clinical trials process. Focusing on real-world examples, Clinilabs will reveal strategies that cut their site initiation [...]
SureClinical has announced the release and FDA compliance validation of SureCTMS, its cloud-based clinical trial management application. As part of SureClinical’s best-in-class platform and suite of eClinical applications, SureCTMS helps teams manage projects more effectively, accelerate project completion milestones, enhance quality, and lower costs. This has helped CROs manage trials more efficiently. “Our users, sponsors, and [...]
